市場調査レポート

商品コード

動物用医薬品調剤市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Animal Drug Compounding Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日: 2022年11月15日 | 発行: Transparency Market Research

| ページ情報: 英文 233 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 5,795 908,424円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,378,704円

レポートPDFを同一の部署内・課内の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,848,984円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートでは、世界の動物用医薬品調剤市場について調査し、市場の概要とともに、2022年～2031年の予測、製品別、動物タイプ別、剤形別、投与経路別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

市場参入企業-競合マトリクス（層および企業規模別）
市場シェア分析、企業別、2021年
企業プロファイル
- Wedgewood Pharmacy
- Triangle Compounding Pharmacy
- Davis Islands Pharmacy
- Custom Med Compounding Pharmacy
- Central Compounding Center South
- Wellness Pharmacy of Cary
- Caringbah Compounding Pharmacy
- Millers Pharmacy
- Smith's Pharmacy
- Specialist Compounding Pharmacy Pte Ltd.
- Tache Pharmacy

図表

List of Tables

Table 01: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017-2031
Table 03: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017-2031
Table 04: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017-2031
Table 05: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017-2031
Table 06: Global Animal Drug Compounding Market Value (US$ My) Forecast, by Others, 2017-2031
Table 07: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
Table 08: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017-2031
Table 09: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 10: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 11: Global Animal Drug Compounding Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 12: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 13: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 14: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017-2031
Table 15: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017-2031
Table 16: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017-2031
Table 17: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017-2031
Table 18: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017-2031
Table 19: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
Table 20: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017-2031
Table 21: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 22: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 23: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 24: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 25: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017-2031
Table 26: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017-2031
Table 27: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017-2031
Table 28: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017-2031
Table 29: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017-2031
Table 30: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
Table 31: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017-2031
Table 32: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 33: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 34: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 35: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 36: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017-2031
Table 37: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017-2031
Table 38: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017-2031
Table 39: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017-2031
Table 40: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017-2031
Table 41: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
Table 42: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017-2031
Table 43: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 44: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 45: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 46: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 47: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017-2031
Table 48: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017-2031
Table 49: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017-2031
Table 50: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017-2031
Table 51: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017-2031
Table 52: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
Table 53: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017-2031
Table 54: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 55: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031
Table 56: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 57: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 58: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-infectives, 2017-2031
Table 59: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2017-2031
Table 60: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by CNS Agents, 2017-2031
Table 61: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by GI Drugs, 2017-2031
Table 62: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Others, 2017-2031
Table 63: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
Table 64: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Companion Animal, 2017-2031
Table 65: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
Table 66: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, by Route of Administration, 2017-2031

List of Figures

Figure 01: Global Animal Drug Compounding Market, by Product, 2021 and 2031
Figure 02: Global Animal Drug Compounding Market Attractiveness Analysis, Product, 2022-2031
Figure 03: Global Animal Drug Compounding Market (US$ Mn), by Anti-infectives, 2017-2031
Figure 04: Global Animal Drug Compounding Market (US$ Mn), by Anti-inflammatory, 2017-2031
Figure 05: Global Animal Drug Compounding Market (US$ Mn), by CNS Agents, 2017-2031
Figure 06: Global Animal Drug Compounding Market (US$ Mn), by GI Drugs, 2017-2031
Figure 07: Global Animal Drug Compounding Market (US$ Mn), by Others, 2017-2031
Figure 08: Global Animal Drug Compounding Market, by Animal Type, 2021 and 2031
Figure 09: Global Animal Drug Compounding Market Attractiveness Analysis, Animal Type, 2022-2031
Figure 10: Global Animal Drug Compounding Market (US$ Mn), by Companion Animal, 2017-2031
Figure 11: Global Animal Drug Compounding Market (US$ Mn), by Livestock Animal, 2017-2031
Figure 12: Global Animal Drug Compounding Market, by Dosage Form, 2021 and 2031
Figure 13: Global Animal Drug Compounding Market Attractiveness Analysis, Dosage Form, 2022-2031
Figure 14: Global Animal Drug Compounding Market (US$ Mn), by Capsules, 2017-2031
Figure 15: Global Animal Drug Compounding Market (US$ Mn), by Solutions, 2017-2031
Figure 16: Global Animal Drug Compounding Market (US$ Mn), by Powders, 2017-2031
Figure 17: Global Animal Drug Compounding Market (US$ Mn), by Suspension, 2017-2031
Figure 18: Global Animal Drug Compounding Market (US$ Mn), by Others, 2017-2031
Figure 19: Global Animal Drug Compounding Market, by Route of Administration, 2021 and 2031
Figure 20: Global Animal Drug Compounding Market Attractiveness Analysis, Route of Administration, 2022-2031
Figure 21: Global Animal Drug Compounding Market (US$ Mn), by Oral, 2017-2031
Figure 22: Global Animal Drug Compounding Market (US$ Mn), by Injectable, 2017-2031
Figure 23: Global Animal Drug Compounding Market (US$ Mn), by Topical, 2017-2031
Figure 24: Global Animal Drug Compounding Market (US$ Mn), by Rectal, 2017-2031
Figure 25: Global Animal Drug Compounding Market (US$ Mn), by Ocular, 2017-2031
Figure 26: Global Animal Drug Compounding Market Value Share Analysis, by Region, 2021 and 2031
Figure 27: Global Animal Drug Compounding Market Attractiveness Analysis, by Region, 2022-2031
Figure 28: North America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 29: North America Animal Drug Compounding Market Value Share Analysis, by Country, 2021 and 2031
Figure 30: North America Animal Drug Compounding Market Attractiveness Analysis, by Country, 2022-2031
Figure 31: North America Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031
Figure 32: North America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022-2031
Figure 33: North America Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031
Figure 34: North America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022-2031
Figure 35: North America Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031
Figure 36: North America Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 37: North America Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 38: North America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 39: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 40: Europe Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 41: Europe Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 42: Europe Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031
Figure 43: Europe Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022-2031
Figure 44: Europe Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031
Figure 45: Europe Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022-2031
Figure 46: Europe Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031
Figure 47: Europe Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 48: Europe Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 49: Europe Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 50: Asia Pacific Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 51: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 52: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 53: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031
Figure 54: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022-2031
Figure 55: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031
Figure 56: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022-2031
Figure 57: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031
Figure 58: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 59: Asia Pacific Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 60: Asia Pacific Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 61: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 62: Latin America Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 63: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 64: Latin America Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031
Figure 65: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022-2031
Figure 66: Latin America Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031
Figure 67: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022-2031
Figure 68: Latin America Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031
Figure 69: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 70: Latin America Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 71: Latin America Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022-2031
Figure 72: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 73: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 74: Middle East and Africa Animal Drug Compounding Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 75: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Product, 2021 and 2031
Figure 76: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Product, 2022-2031
Figure 77: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Animal Type, 2021 and 2031
Figure 78: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Animal Type, 2022-2031
Figure 79: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Dosage Form, 2021 and 2031
Figure 80: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Dosage Form, 2022-2031
Figure 81: Middle East & Africa Animal Drug Compounding Market Value Share Analysis, by Route of Administration, 2021 and 2031
Figure 82: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis, by Route of Administration, 2022-2031

Product Code: TMRGL50493

TMR's report on the global animal drug compounding market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global animal drug compounding market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global animal drug compounding market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the animal drug compounding market.

The report delves into the competitive landscape of the global animal drug compounding market. Key players operating in the global animal drug compounding market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global animal drug compounding market profiled in this report.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Animal Drug Compounding Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Animal Drug Compounding Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Technological Advancements
5.2. Regulatory Scenario by Region/globally
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Animal Drug Compounding Market Analysis and Forecast, by Product

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Anti-invectives
  - 6.3.1.1. Metranidazole
  - 6.3.1.2. Ketaconazole
  - 6.3.1.3. Other Anti invectives
- 6.3.2. Anti-inflammatory
  - 6.3.2.1. Prednisolone
  - 6.3.2.2. Tramadol
  - 6.3.2.3. Others
- 6.3.3. CNS Agents
  - 6.3.3.1. Potassium bromide
  - 6.3.3.2. Gabapentin
  - 6.3.3.3. Other CNS agents
- 6.3.4. GI Drugs
  - 6.3.4.1. Apomorphine
  - 6.3.4.2. Ursodiol
  - 6.3.4.3. Cisapride
  - 6.3.4.4. Other GI Drugs
- 6.3.5. Others
6.4. Market Attractiveness Analysis, by Product

7. Global Animal Drug Compounding Market Analysis and Forecast, by Animal Type

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Animal Type, 2017-2031
- 7.3.1. Companion Animal
  - 7.3.1.1. Dogs
  - 7.3.1.2. Cats
  - 7.3.1.3. Others
- 7.3.2. Live Stock
7.4. Market Attractiveness Analysis, by Animal Type

8. Global Animal Drug Compounding Market Analysis and Forecast, by Dosage Form

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Dosage Form, 2017-2031
- 8.3.1. Capsules
- 8.3.2. Solutions
- 8.3.3. Powders
- 8.3.4. Suspension
- 8.3.5. Others
8.4. Market Attractiveness Analysis, by Dosage Form

9. Global Animal Drug Compounding Market Analysis and Forecast, by Route of Administration

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Route of Administration, 2017-2031
- 9.3.1. Oral
- 9.3.2. Injectable
- 9.3.3. Topical
- 9.3.4. Rectal
- 9.3.5. Ocular
9.4. Market Attractiveness Analysis, by Route of Administration

10. Global Animal Drug Compounding Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region

11. North America Animal Drug Compounding Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Anti-infectives
  - 11.2.1.1. Metranidazole
  - 11.2.1.2. Ketaconazole
  - 11.2.1.3. Other Anti-infectives
- 11.2.2. Anti-inflammatory
  - 11.2.2.1. Prednisolone
  - 11.2.2.2. Tramadol
  - 11.2.2.3. Others
- 11.2.3. CNS Agents
  - 11.2.3.1. Potassium bromide
  - 11.2.3.2. Gabapentin
  - 11.2.3.3. Other CNS agents
- 11.2.4. GI Drugs
  - 11.2.4.1. Apomorphine
  - 11.2.4.2. Ursodiol
  - 11.2.4.3. Cisapride
  - 11.2.4.4. Other GI Drugs
- 11.2.5. Others
11.3. Market Value Forecast, by Animal Type, 2017-2031
- 11.3.1. Companion Animal
  - 11.3.1.1. Dogs
  - 11.3.1.2. Cats
  - 11.3.1.3. Others
- 11.3.2. Live Stock
11.4. Market Value Forecast, by Dosage Form, 2017-2031
- 11.4.1. Capsules
- 11.4.2. Solutions
- 11.4.3. Powders
- 11.4.4. Suspension
- 11.4.5. Others
11.5. Market Value Forecast, by Route of Administration, 2017-2031
- 11.5.1. Oral
- 11.5.2. Injectable
- 11.5.3. Topical
- 11.5.4. Rectal
- 11.5.5. Ocular
11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Product
- 11.7.2. By Animal Type
- 11.7.3. By Dosage Form
- 11.7.4. By Route of Administration
- 11.7.5. By Country

12. Europe Animal Drug Compounding Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Anti-infectives
  - 12.2.1.1. Metranidazole
  - 12.2.1.2. Ketaconazole
  - 12.2.1.3. Other Anti-infectives
- 12.2.2. Anti-inflammatory
  - 12.2.2.1. Prednisolone
  - 12.2.2.2. Tramadol
  - 12.2.2.3. Others
- 12.2.3. CNS Agents
  - 12.2.3.1. Potassium bromide
  - 12.2.3.2. Gabapentin
  - 12.2.3.3. Other CNS agents
- 12.2.4. GI Drugs
  - 12.2.4.1. Apomorphine
  - 12.2.4.2. Ursodiol
  - 12.2.4.3. Cisapride
  - 12.2.4.4. Other GI Drugs
- 12.2.5. Others
12.3. Market Value Forecast, by Animal Type, 2017-2031
- 12.3.1. Companion Animal
  - 12.3.1.1. Dogs
  - 12.3.1.2. Cats
  - 12.3.1.3. Others
- 12.3.2. Live Stock
12.4. Market Value Forecast, by Dosage Form, 2017-2031
- 12.4.1. Capsules
- 12.4.2. Solutions
- 12.4.3. Powders
- 12.4.4. Suspension
- 12.4.5. Others
12.5. Market Value Forecast, by Route of Administration, 2017-2031
- 12.5.1. Oral
- 12.5.2. Injectable
- 12.5.3. Topical
- 12.5.4. Rectal
- 12.5.5. Ocular
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Product
- 12.7.2. By Animal Type
- 12.7.3. By Dosage Form
- 12.7.4. By Route of Administration
- 12.7.5. By Country/Sub-region

13. Asia Pacific Animal Drug Compounding Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Anti-infectives
  - 13.2.1.1. Metranidazole
  - 13.2.1.2. Ketaconazole
  - 13.2.1.3. Other Anti-infectives
- 13.2.2. Anti-inflammatory
  - 13.2.2.1. Prednisolone
  - 13.2.2.2. Tramadol
  - 13.2.2.3. Others
- 13.2.3. CNS Agents
  - 13.2.3.1. Potassium bromide
  - 13.2.3.2. Gabapentin
  - 13.2.3.3. Other CNS agents
- 13.2.4. GI Drugs
  - 13.2.4.1. Apomorphine
  - 13.2.4.2. Ursodiol
  - 13.2.4.3. Cisapride
  - 13.2.4.4. Other GI Drugs
- 13.2.5. Others
13.3. Market Value Forecast, by Animal Type, 2017-2031
- 13.3.1. Companion Animal
  - 13.3.1.1. Dogs
  - 13.3.1.2. Cats
  - 13.3.1.3. Others
- 13.3.2. Live Stock
13.4. Market Value Forecast, by Dosage Form, 2017-2031
- 13.4.1. Capsules
- 13.4.2. Solutions
- 13.4.3. Powders
- 13.4.4. Suspension
- 13.4.5. Others
13.5. Market Value Forecast, by Route of Administration, 2017-2031
- 13.5.1. Oral
- 13.5.2. Injectable
- 13.5.3. Topical
- 13.5.4. Rectal
- 13.5.5. Ocular
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Product
- 13.7.2. By Animal Type
- 13.7.3. By Dosage Form
- 13.7.4. By Route of Administration
- 13.7.5. By Country/Sub-region

14. Latin America Animal Drug Compounding Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Anti-infectives
  - 14.2.1.1. Metranidazole
  - 14.2.1.2. Ketaconazole
  - 14.2.1.3. Other Anti-infectives
- 14.2.2. Anti-inflammatory
  - 14.2.2.1. Prednisolone
  - 14.2.2.2. Tramadol
  - 14.2.2.3. Other Anti-inflammatory
- 14.2.3. CNS Agents
  - 14.2.3.1. Potassium bromide
  - 14.2.3.2. Gabapentin
  - 14.2.3.3. Other CNS agents
- 14.2.4. GI Drugs
  - 14.2.4.1. Apomorphine
  - 14.2.4.2. Ursodiol
  - 14.2.4.3. Cisapride
  - 14.2.4.4. Other GI Drugs
- 14.2.5. Others
14.3. Market Value Forecast, by Animal Type, 2017-2031
- 14.3.1. Companion Animal
  - 14.3.1.1. Dogs
  - 14.3.1.2. Cats
  - 14.3.1.3. Others
- 14.3.2. Live Stock
14.4. Market Value Forecast, by Dosage Form, 2017-2031
- 14.4.1. Capsules
- 14.4.2. Solutions
- 14.4.3. Powders
- 14.4.4. Suspension
- 14.4.5. Others
14.5. Market Value Forecast, by Route of Administration, 2017-2031
- 14.5.1. Oral
- 14.5.2. Injectable
- 14.5.3. Topical
- 14.5.4. Rectal
- 14.5.5. Ocular
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Product
- 14.7.2. By Animal Type
- 14.7.3. By Dosage Form
- 14.7.4. By Route of Administration
- 14.7.5. By Country/Sub-region

15. Middle East & Africa Animal Drug Compounding Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Anti-infectives
  - 15.2.1.1. Metranidazole
  - 15.2.1.2. Ketaconazole
  - 15.2.1.3. Other Anti-infectives
- 15.2.2. Anti-inflammatory
  - 15.2.2.1. Prednisolone
  - 15.2.2.2. Tramadol
  - 15.2.2.3. Other Anti-inflammatory
- 15.2.3. CNS Agents
  - 15.2.3.1. Potassium bromide
  - 15.2.3.2. Gabapentin
  - 15.2.3.3. Other CNS agents
- 15.2.4. GI Drugs
  - 15.2.4.1. Apomorphine
  - 15.2.4.2. Ursodiol
  - 15.2.4.3. Cisapride
  - 15.2.4.4. Other GI Drugs
- 15.2.5. Others
15.3. Market Value Forecast, by Animal Type, 2017-2031
- 15.3.1. Companion Animal
  - 15.3.1.1. Dogs
  - 15.3.1.2. Cats
  - 15.3.1.3. Others
- 15.3.2. Live Stock
15.4. Market Value Forecast, by Dosage Form, 2017-2031
- 15.4.1. Capsules
- 15.4.2. Solutions
- 15.4.3. Powders
- 15.4.4. Suspension
- 15.4.5. Others
15.5. Market Value Forecast, by Route of Administration, 2017-2031
- 15.5.1. Oral
- 15.5.2. Injectable
- 15.5.3. Topical
- 15.5.4. Rectal
- 15.5.5. Ocular
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Country
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Product
- 15.7.2. By Animal Type
- 15.7.3. By Dosage Form
- 15.7.4. By Route of Administration
- 15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
- 16.3.1. Wedgewood Pharmacy
  - 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.1.2. Company Financials
  - 16.3.1.3. Growth Strategies
  - 16.3.1.4. SWOT Analysis
- 16.3.2. Triangle Compounding Pharmacy
  - 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.2.2. Company Financials
  - 16.3.2.3. Growth Strategies
  - 16.3.2.4. SWOT Analysis
- 16.3.3. Davis Islands Pharmacy
  - 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.3.2. Company Financials
  - 16.3.3.3. Growth Strategies
  - 16.3.3.4. SWOT Analysis
- 16.3.4. Custom Med Compounding Pharmacy
  - 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.4.2. Company Financials
  - 16.3.4.3. Growth Strategies
  - 16.3.4.4. SWOT Analysis
- 16.3.5. Central Compounding Center South
  - 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.5.2. Company Financials
  - 16.3.5.3. Growth Strategies
  - 16.3.5.4. SWOT Analysis
- 16.3.6. Wellness Pharmacy of Cary
  - 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.6.2. Company Financials
  - 16.3.6.3. Growth Strategies
  - 16.3.6.4. SWOT Analysis
- 16.3.7. Caringbah Compounding Pharmacy
  - 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.7.2. Company Financials
  - 16.3.7.3. Growth Strategies
  - 16.3.7.4. SWOT Analysis
- 16.3.8. Millers Pharmacy
  - 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.8.2. Company Financials
  - 16.3.8.3. Growth Strategies
  - 16.3.8.4. SWOT Analysis
- 16.3.9. Smith's Pharmacy
  - 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.9.2. Company Financials
  - 16.3.9.3. Growth Strategies
  - 16.3.9.4. SWOT Analysis
- 16.3.10. Specialist Compounding Pharmacy Pte Ltd.
  - 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.10.2. Company Financials
  - 16.3.10.3. Growth Strategies
  - 16.3.10.4. SWOT Analysis
- 16.3.11. Tache Pharmacy
  - 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 16.3.11.2. Company Financials
  - 16.3.11.3. Growth Strategies
  - 16.3.11.4. SWOT Analysis

動物用医薬品調剤市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Animal Drug Compounding Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

目次

第1章序文

第2章前提と調査手法

第3章エグゼクティブサマリー：世界の動物用医薬品調剤市場

第4章市場概要

第5章主な洞察

第6章世界の動物用医薬品調剤市場の分析と予測、製品別

第7章世界の動物用医薬品調剤市場の分析と予測、動物タイプ別

第8章世界の動物用医薬品調剤市場の分析と予測、剤形別

第9章世界の動物用医薬品調剤市場の分析と予測、投与経路別

第10章世界の動物用医薬品調剤市場の分析と予測、地域別

第11章北米の動物用医薬品調剤市場の分析と予測

第12章欧州の動物用医薬品調剤市場の分析と予測

第13章アジア太平洋の動物用医薬品調剤市場の分析と予測

第14章ラテンアメリカの動物用医薬品調剤市場の分析と予測

第15章中東・アフリカの動物用医薬品調剤市場の分析と予測

第16章競合情勢

List of Tables

List of Figures

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Animal Drug Compounding Market

4. Market Overview

5. Key Insights

6. Global Animal Drug Compounding Market Analysis and Forecast, by Product

7. Global Animal Drug Compounding Market Analysis and Forecast, by Animal Type

8. Global Animal Drug Compounding Market Analysis and Forecast, by Dosage Form

9. Global Animal Drug Compounding Market Analysis and Forecast, by Route of Administration

10. Global Animal Drug Compounding Market Analysis and Forecast, by Region

11. North America Animal Drug Compounding Market Analysis and Forecast

12. Europe Animal Drug Compounding Market Analysis and Forecast

13. Asia Pacific Animal Drug Compounding Market Analysis and Forecast

14. Latin America Animal Drug Compounding Market Analysis and Forecast

15. Middle East & Africa Animal Drug Compounding Market Analysis and Forecast

16. Competition Landscape

動物用医薬品調剤市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Animal Drug Compounding Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー：世界の動物用医薬品調剤市場

第4章 市場概要

第5章 主な洞察

第6章 世界の動物用医薬品調剤市場の分析と予測、製品別

第7章 世界の動物用医薬品調剤市場の分析と予測、動物タイプ別

第8章 世界の動物用医薬品調剤市場の分析と予測、剤形別

第9章 世界の動物用医薬品調剤市場の分析と予測、投与経路別

第10章 世界の動物用医薬品調剤市場の分析と予測、地域別

第11章 北米の動物用医薬品調剤市場の分析と予測

第12章 欧州の動物用医薬品調剤市場の分析と予測

第13章 アジア太平洋の動物用医薬品調剤市場の分析と予測

第14章 ラテンアメリカの動物用医薬品調剤市場の分析と予測

第15章 中東・アフリカの動物用医薬品調剤市場の分析と予測

第16章 競合情勢

List of Tables

List of Figures

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Animal Drug Compounding Market

4. Market Overview

5. Key Insights

6. Global Animal Drug Compounding Market Analysis and Forecast, by Product

7. Global Animal Drug Compounding Market Analysis and Forecast, by Animal Type

8. Global Animal Drug Compounding Market Analysis and Forecast, by Dosage Form

9. Global Animal Drug Compounding Market Analysis and Forecast, by Route of Administration

10. Global Animal Drug Compounding Market Analysis and Forecast, by Region

11. North America Animal Drug Compounding Market Analysis and Forecast

12. Europe Animal Drug Compounding Market Analysis and Forecast

13. Asia Pacific Animal Drug Compounding Market Analysis and Forecast

14. Latin America Animal Drug Compounding Market Analysis and Forecast

15. Middle East & Africa Animal Drug Compounding Market Analysis and Forecast

16. Competition Landscape

第1章序文

第2章前提と調査手法

第3章エグゼクティブサマリー：世界の動物用医薬品調剤市場

第4章市場概要

第5章主な洞察

第6章世界の動物用医薬品調剤市場の分析と予測、製品別

第7章世界の動物用医薬品調剤市場の分析と予測、動物タイプ別

第8章世界の動物用医薬品調剤市場の分析と予測、剤形別

第9章世界の動物用医薬品調剤市場の分析と予測、投与経路別

第10章世界の動物用医薬品調剤市場の分析と予測、地域別

第11章北米の動物用医薬品調剤市場の分析と予測

第12章欧州の動物用医薬品調剤市場の分析と予測

第13章アジア太平洋の動物用医薬品調剤市場の分析と予測

第14章ラテンアメリカの動物用医薬品調剤市場の分析と予測

第15章中東・アフリカの動物用医薬品調剤市場の分析と予測

第16章競合情勢